Company Overview and Strategy - SRx Health Solutions was founded in 2013 with a patient-centric approach to specialty pharmacy care[13] - The company has expanded to 20 pharmacies, 34 clinics, and 4 clinical trial sites across Canada[14] - SRx entered the U S market by signing a letter of intent to acquire 100% of Choice Specialty Pharmacy Group, which has five sites in Texas and licenses to distribute across 26 states[16] - SRx aims to create a comprehensive North American healthcare network by integrating its Canadian operations with the acquired U S operations[55] Market Opportunity - 73% of Canadians aged 65+ report having at least one chronic disease[39] - 33% of Canadians aged 65+ report having two or more chronic diseases[39] - 52% of Canadians aged 60+ take three or more prescription medications[39] - U S specialty drug spend represents approximately 51% of total 2024 U S drug purchases, amounting to ~$410 billion[41] - U S specialty drug spend growth in 2024 was ~11 9%, compared to 8 1% for traditional drugs[41] Financials and Capitalization - The pro forma combined net debt is $39 4 million[51] - Insiders own 75%+ of the company, while non-affiliates own 25%[51]
SRx Health Solutions (BTTR) Earnings Call Presentation